BEUDAMED
    69 results · 52ms · Sources: EU EUDAMED, US FDA

    FacetFuse®

    FDA UDI
    SPINEFRONTIER, INC.·00190361019664·Facet Screw Assy, SOTW, Fixed 16, 4.5x40

    FacetFuse®

    FDA UDI
    SPINEFRONTIER, INC.·00190361019688·Facet Screw Assy, SOTW, Fixed 16, 4.5x50

    FacetFuse®

    FDA UDI
    SPINEFRONTIER, INC.·00190361019749·Facet Screw Assy, SOTW, Fixed 16, 5.5x40

    FacetFuse®

    FDA UDI
    SPINEFRONTIER, INC.·00190361019718·Facet Screw Assy, SOTW, Fixed 16, 5.0x45

    FacetFuse®

    FDA UDI
    SPINEFRONTIER, INC.·00190361019725·Facet Screw Assy, SOTW, Fixed 16, 5.0x50

    FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR, MODEL KD-557

    FDA 510(k)
    FDA Class 2 ·Cardiovascular

    O2/CO2 NASAL FILTERLINE

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    I_OPEN 0.4T

    FDA 510(k)
    FDA Class 2 ·Radiology

    I OPEN 0.5T

    FDA 510(k)
    FDA Class 2 ·Radiology

    i_Space 1.5T Superconducting Magnetic Resonance Imaging System

    FDA 510(k)
    FDA Class 2 ·Radiology

    i_ Field 1.5T Superconducting Magnetic Resonance Imaging System

    FDA 510(k)
    FDA Class 2 ·Radiology

    I OPEN 0.36 T-MAGNETIC RESONANCE IMAGING SYSTEM

    FDA 510(k)
    FDA Class 2 ·Radiology

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMADX KIT

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT